Running out of money and no progress with FDA, not hardly even any mention of that at all. Clutching at straws with random antibiotic initiatives in other countries. Disappointing.
- Forums
- ASX - By Stock
- RCE
- Ann: Appendix 4C and commentary
RCE
recce pharmaceuticals ltd
Add to My Watchlist
0.00%
!
30.0¢

Ann: Appendix 4C and commentary, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.51M |
Open | High | Low | Value | Volume |
30.0¢ | 30.0¢ | 30.0¢ | $6.3K | 21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10500 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 12600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10500 | 0.300 |
1 | 20000 | 0.295 |
4 | 145855 | 0.290 |
4 | 85000 | 0.285 |
14 | 352889 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 1041 | 1 |
0.310 | 231 | 1 |
0.325 | 12831 | 2 |
0.340 | 231 | 1 |
0.350 | 31319 | 3 |
Last trade - 13.49pm 03/07/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online